Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells

Završnik, Janja ; Butinar, Miha ; Prebanda, Mojca Trstenjak ; Krajnc, Aleksander ; Vidmar, Robert ; Fonović, Marko ; Grubb, Anders LU orcid ; Turk, Vito ; Turk, Boris and Vasiljeva, Olga (2017) In Oncotarget 8(43). p.73793-73809
Abstract

Cysteine cathepsins are proteases that, in addition to their important physiological functions, have been associated with multiple pathologies, including cancer. Cystatin C (CstC) is a major endogenous inhibitor that regulates the extracellular activity of cysteine cathepsins. We investigated the role of cystatin C in mammary cancer using CstC knockout mice and a mouse model of breast cancer induced by expression of the polyoma middle T oncoprotein (PyMT) in the mammary epithelium. We showed that the ablation of CstC reduced the rate of mammary tumor growth. Notably, a decrease in the proliferation of CstC knockout PyMT tumor cells was demonstrated ex vivo and in vitro, indicating a role for this protease inhibitor in signaling pathways... (More)

Cysteine cathepsins are proteases that, in addition to their important physiological functions, have been associated with multiple pathologies, including cancer. Cystatin C (CstC) is a major endogenous inhibitor that regulates the extracellular activity of cysteine cathepsins. We investigated the role of cystatin C in mammary cancer using CstC knockout mice and a mouse model of breast cancer induced by expression of the polyoma middle T oncoprotein (PyMT) in the mammary epithelium. We showed that the ablation of CstC reduced the rate of mammary tumor growth. Notably, a decrease in the proliferation of CstC knockout PyMT tumor cells was demonstrated ex vivo and in vitro, indicating a role for this protease inhibitor in signaling pathways that control cell proliferation. An increase in phosphorylated p-38 was observed in CstC knockout tumors, suggesting a novel function for cystatin C in cancer development, independent of the TGF-β pathway. Moreover, proteomic analysis of the CstC wild-type and knockout PyMT primary cell secretomes revealed a decrease in the levels of 14-3-3 proteins in the secretome of knock-out cells, suggesting a novel link between cysteine cathepsins, cystatin C and 14-3-3 proteins in tumorigenesis, calling for further investigations.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Breast cancer, Cathepsin inhibitor, Cystatin C, Mouse model
in
Oncotarget
volume
8
issue
43
pages
17 pages
publisher
Impact Journals
external identifiers
  • scopus:85030103088
  • pmid:29088746
  • wos:000411760400038
ISSN
1949-2553
DOI
10.18632/oncotarget.17379
language
English
LU publication?
yes
id
072870b5-61d5-445c-8d37-bd5759db0a7c
date added to LUP
2017-11-07 15:35:43
date last changed
2024-10-14 16:35:01
@article{072870b5-61d5-445c-8d37-bd5759db0a7c,
  abstract     = {{<p>Cysteine cathepsins are proteases that, in addition to their important physiological functions, have been associated with multiple pathologies, including cancer. Cystatin C (CstC) is a major endogenous inhibitor that regulates the extracellular activity of cysteine cathepsins. We investigated the role of cystatin C in mammary cancer using CstC knockout mice and a mouse model of breast cancer induced by expression of the polyoma middle T oncoprotein (PyMT) in the mammary epithelium. We showed that the ablation of CstC reduced the rate of mammary tumor growth. Notably, a decrease in the proliferation of CstC knockout PyMT tumor cells was demonstrated ex vivo and in vitro, indicating a role for this protease inhibitor in signaling pathways that control cell proliferation. An increase in phosphorylated p-38 was observed in CstC knockout tumors, suggesting a novel function for cystatin C in cancer development, independent of the TGF-β pathway. Moreover, proteomic analysis of the CstC wild-type and knockout PyMT primary cell secretomes revealed a decrease in the levels of 14-3-3 proteins in the secretome of knock-out cells, suggesting a novel link between cysteine cathepsins, cystatin C and 14-3-3 proteins in tumorigenesis, calling for further investigations.</p>}},
  author       = {{Završnik, Janja and Butinar, Miha and Prebanda, Mojca Trstenjak and Krajnc, Aleksander and Vidmar, Robert and Fonović, Marko and Grubb, Anders and Turk, Vito and Turk, Boris and Vasiljeva, Olga}},
  issn         = {{1949-2553}},
  keywords     = {{Breast cancer; Cathepsin inhibitor; Cystatin C; Mouse model}},
  language     = {{eng}},
  number       = {{43}},
  pages        = {{73793--73809}},
  publisher    = {{Impact Journals}},
  series       = {{Oncotarget}},
  title        = {{Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells}},
  url          = {{http://dx.doi.org/10.18632/oncotarget.17379}},
  doi          = {{10.18632/oncotarget.17379}},
  volume       = {{8}},
  year         = {{2017}},
}